Livzon Pharmaceutical Group Inc. announced that in 2024, the revenue is 11.812 billion yuan, a year-on-year decrease of 4.97%. The Net income attributable to shareholders of the listed company is 2.061 billion yuan, an increase of 5.50% year-on-year. The company intends to distribute a cash dividend of 11 yuan (including tax) for every 10 shares to all shareholders.
Clear
All
Quotes
News
Learn
Help
All
HK
US
CN
SG
AU
JP
All
News
Announcements
Reports
No matches yet
Operations too frequent. Please try again later.
Please check network settings and try again Refresh
Refresh
Loading
History record
Latest News
-
One Week Ahead | Trump's "reciprocal tariffs" are about to be implemented! It may become a turning point for Global Assets; Non-farm payrolls and Powell take turns to "shake the market"! The "temporary inflation theory" is attracting much attention; the H
Weekend Reading | The AI Battlefield in the Real World: Why are Global Top Enterprises Choosing to Collaborate with Alibaba?
Bank of China, Bank of Communications, China Construction Bank, Postal Savings Bank Of China, collectively announce! Planning to raise 520 billion yuan from the Ministry of Finance and others!
Quotes
More
News
More
Learn
More
Help
More
Loading
News
More
Announcements
More
Reports
More
丽珠集团:2024年净利润20.61亿元 同比增长5.50%
Livzon Pharmaceutical Group Inc.: In 2024, the Net income is 2.061 billion yuan, a year-on-year increase of 5.50%.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Like
Views 281
Write a comment
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.
Comment(0)
Reason For Report